CDX
Hs 695T
Tumor indication
Skin
Tumor subtype
Ameloanotic Melanoma
Description
HS 695T (Melanoma CDX Model)
The HS 695T melanoma line was derived from a metastatic melanoma lesion. It is representative of aggressive melanoma progression. HS 695T has been applied in preclinical research focused on therapy resistance. Its reproducibility makes it a reliable system for translational oncology.
Key Features:
- Derived from metastatic melanoma.
- Represents advanced melanoma biology.
- Highly tumorigenic in xenografts.
- Suitable for resistance mechanism studies.
Applications:
HS 695T is used in testing novel therapeutics for metastatic melanoma. It supports drug resistance and biomarker discovery programs. Researchers employ it to investigate mechanisms of tumor progression. Its aggressive phenotype makes it valuable for late-stage melanoma studies.
Details
- Tumor indication
- Skin
- Tumor subtype
- Ameloanotic Melanoma
- Organism
- Human
- Mouse sex
- Female
Mutated genes
Select a gene to see the variants recorded for this line.
Gene expression
Show all values
| Gene | Expression |
|---|
Expression measured across the Champions panel.
Request this cell line
Let's build the right study, together.
Backed by deep expertise in these models, our team will work with you to design the study around your target, line of therapy, and endpoint.